» Articles » PMID: 27096319

Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment

Abstract

Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.

Citing Articles

Chemokine associations with blood cerebrospinal fluid (CSF) barrier permeability and delirium.

Denver P, Tortorelli L, Hov K, Berg J, Giil L, Nazmi A Brain Behav Immun Health. 2025; 43():100920.

PMID: 39839987 PMC: 11750293. DOI: 10.1016/j.bbih.2024.100920.


Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease.

Mandolfo O, Parker H, Aguado E, Learmonth Y, Liao A, OLeary C EMBO Mol Med. 2024; 16(7):1579-1602.

PMID: 38890537 PMC: 11251277. DOI: 10.1038/s44321-024-00092-4.


The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies.

Viengkhou B, Hayashida E, McGlasson S, Emelianova K, Forbes D, Wiseman S Immunity. 2024; 57(7):1696-1709.e10.

PMID: 38878770 PMC: 11250091. DOI: 10.1016/j.immuni.2024.05.017.


Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10.

Soloey-Nilsen H, Nygaard-Odeh K, Kristiansen M, Kvig E, Brekke O, Mollnes T Clin Psychopharmacol Neurosci. 2024; 22(2):285-294.

PMID: 38627075 PMC: 11024699. DOI: 10.9758/cpn.23.1091.


Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer's disease.

Vavougios G, Tseriotis V, Liampas A, Mavridis T, de Erausquin G, Hadjigeorgiou G Front Hum Neurosci. 2024; 18:1352118.

PMID: 38562226 PMC: 10982434. DOI: 10.3389/fnhum.2024.1352118.